Accès ouvert
2026
article
OpenAlex
Ziwei Wang, Wei He, Maoyu Wang, Meimian Hua et autres
BACKGROUND: Molecular subtyping of bladder cancer (BCa) using bulk transcriptomic data is hindered by tumor microenvironment (TME) contamination and intra-tumoral heterogeneity. These factors also contribute to variable responses to immune checkpoint inhibitor (ICI) therapy. Single-cell RNA sequencing offers a high-resolution approach to …
cn
(code pays fourni par la source)
Accès ouvert
2026
article
OpenAlex
Hui Zhang, Chen Zhang, Jinshan Xu, Maoyu Wang et autres
Background: Transurethral resection of bladder tumor (TURBT) is the core surgical procedure for the diagnosis and treatment of bladder cancer, with significant variations in its surgical complexity that directly affect the difficulty of surgical operation, the risk of perioperative complications, and the …
cn
(code pays fourni par la source)
2026
article
OpenAlex
Xufeng Yu, Rongjie Wu, Chen Zhang, Jiaxin Xie et autres
cn
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Wei He, Yuchen Li, Qing Chen, Ziwei Wang et autres
BACKGROUND: Breast and urogenital tumors are relatively rare in children and adolescents, with sparse and fragmented data on their global disease burden, lacking comprehensive epidemiological assessment. METHODS: Using Global Burden of Disease (GBD) 2021 data, we analyzed incidence, mortality, prevalence, and disability-adjusted …
cn
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Ziwei Wang, Jiaying Miao, Maoyu Wang, Yidie Ying et autres
BACKGROUND: While single-cell technologies have advanced bladder cancer research, the microenvironment of lymph node metastases and its role in progression remain unclear. We aimed to elucidate dynamic tumor-microenvironment interactions across metastatic and primary sites, identify poor-prognosis features, and uncover novel therapeutic targets. …
cn
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Wei He, Ziwei Wang, Maoyu Wang, Qing Chen et autres
BACKGROUND: Radical cystectomy (RC) with neoadjuvant chemotherapy (NAC) and pelvic lymph node dissection (PLND) is standard for muscle-invasive bladder cancer (MIBC). While PLND improves staging and local control, the optimal extent is debated. This study used the SEER database (2000–2021) to evaluate …
cn
(code pays fourni par la source)
2025
conference-paper
OpenAlex
Xiaodong Yue, Maoyu Wang, Zhikang Xu, Yufei Chen et autres
cn
(code pays fourni par la source)
2025
article
OpenAlex
Jinshan Xu, Guandan Wang, Maoyu Wang, Xi Xu et autres
cn
(code pays fourni par la source)
2025
letter
OpenAlex
Wei He, Maoyu Wang, Chen Zhang, Shuxiong Zeng et autres
cn
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Jing Liu, Maoyu Wang, Xiang Chen, Jinshan Xu et autres
BACKGROUND: Bladder cancer (BCa) is a prevalent and lethal malignancy of the urinary system. Recent evidence suggests a strong association between the urinary microbiota and the pathogenesis, progression, and prognosis of BCa. This study investigated the role of the urinary microbiota in …
cn
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Wei He, Jiaxin Xie, Ziwei Wang, Maoyu Wang et autres
As the feasibility of risk-adaptive bladder-sparing treatment is increasingly validated, the prospects for neoadjuvant therapy in muscle-invasive bladder cancer (MIBC) are rapidly evolving. For patients seeking effective and tolerable treatment options, platinum-based chemotherapy, particularly dose-dense MVAC (ddMVAC), remains the preferred standard. However, …
cn
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Jinshan Xu, Maoyu Wang, Xi Jin Xu, Jin-Peng Zhu et autres
BACKGROUND: Bladder cancer (BCa) is a common urinary malignancy with high recurrence rates in non-muscle invasive bladder cancer (NMIBC), posing significant clinical challenges. Emerging evidence links urinary microbiota to cancer progression; however, their role in BCa recurrence remains unclear. This study aimed …
cn
(code pays fourni par la source)